Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$6.52 - $20.32 $782,400 - $2.44 Million
120,000 New
120,000 $2.26 Million
Q2 2021

Aug 16, 2021

SELL
$26.34 - $46.62 $2.9 Million - $5.13 Million
-110,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$45.96 - $68.02 $5.06 Million - $7.48 Million
110,000 New
110,000 $5.57 Million
Q3 2020

Nov 12, 2020

SELL
$10.54 - $18.47 $421,599 - $738,800
-40,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$10.37 - $20.64 $414,799 - $825,600
40,000 New
40,000 $728,000
Q3 2019

Nov 12, 2019

SELL
$8.95 - $15.72 $268,500 - $471,600
-30,000 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$14.61 - $22.45 $438,300 - $673,500
30,000 New
30,000 $476,000
Q3 2018

Nov 09, 2018

SELL
$13.39 - $26.25 $80,340 - $157,500
-6,000 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$15.0 - $25.6 $90,000 - $153,600
6,000 New
6,000 $94,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.